These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31210924)

  • 21. Deprescribing Statins and Proton Pump Inhibitors in Nursing Home Residents; a Pragmatic Exploratory Study.
    Visser AGR; Schols JMGA; Prevoo MALM; Janknegt R; Winkens B
    Gerontol Geriatr Med; 2021; 7():23337214211050807. PubMed ID: 35187202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating an inpatient deprescribing initiative at a rural community hospital in Ontario.
    Gazarin M; Devin B; Tse D; Mulligan E; Naciuk M; Duncan S; Burnett S; Hall L; Elbeddini A
    Can Pharm J (Ott); 2020; 153(4):224-231. PubMed ID: 33193924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of pharmacist-led physician-supported inpatient deprescribing model in older patients admitted to an acute general medical unit.
    Potter EL; Lew TE; Sooriyakumaran M; Edwards AM; Tong E; Aung AK
    Australas J Ageing; 2019 Sep; 38(3):206-210. PubMed ID: 30868694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.
    Galazzi A; Lusignani M; Chiarelli MT; Mannucci PM; Franchi C; Tettamanti M; Reeve E; Nobili A
    Int J Clin Pharm; 2016 Apr; 38(2):454-61. PubMed ID: 26951120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial.
    Aharaz A; Rasmussen JH; McNulty HBØ; Cyron A; Fabricius PK; Bengaard AK; Sejberg HRC; Simonsen RRL; Treldal C; Houlind MB
    Metabolites; 2021 Mar; 11(4):. PubMed ID: 33808080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study.
    Evrard P; Henrard S; Foulon V; Spinewine A
    J Am Geriatr Soc; 2020 Dec; 68(12):2768-2777. PubMed ID: 32786002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care.
    McDonald EG; Wu PE; Rashidi B; Forster AJ; Huang A; Pilote L; Papillon-Ferland L; Bonnici A; Tamblyn R; Whitty R; Porter S; Battu K; Downar J; Lee TC
    J Am Geriatr Soc; 2019 Sep; 67(9):1843-1850. PubMed ID: 31250427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are high-care nursing home residents at greater risk of unplanned hospital admission than other elderly patients when exposed to Beers potentially inappropriate medications?
    Price SD; Holman CD; Sanfilippo FM; Emery JD
    Geriatr Gerontol Int; 2014 Oct; 14(4):934-41. PubMed ID: 24299444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.
    Thillainadesan J; Gnjidic D; Green S; Hilmer SN
    Drugs Aging; 2018 Apr; 35(4):303-319. PubMed ID: 29541966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
    Anderson K; Freeman C; Foster M; Scott I
    J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between potentially inappropriate medications at discharge and unplanned readmissions among hospitalised elderly patients at a single centre in Japan: a prospective observational study.
    Komagamine J; Yabuki T; Kobayashi M
    BMJ Open; 2019 Nov; 9(11):e032574. PubMed ID: 31699748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Implications of Potentially Inappropriate Prescribing According to STOPP/START Version 2 Criteria in Older Polymorbid Patients Discharged From Geriatric and Internal Medicine Wards: A Prospective Observational Multicenter Study.
    Brunetti E; Aurucci ML; Boietti E; Gibello M; Sappa M; Falcone Y; Cappa G; Bo M
    J Am Med Dir Assoc; 2019 Nov; 20(11):1476.e1-1476.e10. PubMed ID: 31109910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive Deprescribing in Older Adult Veterans at End of Life Admitted to Veteran Affairs Nursing Homes.
    Vu M; Sileanu FE; Aspinall SL; Niznik JD; Springer SP; Mor MK; Zhao X; Ersek M; Hanlon JT; Gellad WF; Schleiden LJ; Thorpe JM; Thorpe CT
    J Am Med Dir Assoc; 2021 Jan; 22(1):132-140.e5. PubMed ID: 32723537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
    Balsom C; Pittman N; King R; Kelly D
    Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.
    Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D
    Int J Clin Pharm; 2015 Oct; 37(5):949-57. PubMed ID: 26047944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A medication review and deprescribing method for hospitalised older patients receiving multiple medications.
    McKean M; Pillans P; Scott IA
    Intern Med J; 2016 Jan; 46(1):35-42. PubMed ID: 26387783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-risk medications in older patients with trauma: a cross-sectional study of risk mitigation.
    Lester E; Dykstra M; Grant C; Fawcett V; Tsang B; Widder S
    Can J Surg; 2019 Apr; 62(2):100-104. PubMed ID: 30907565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
    Bolmsjö BB; Palagyi A; Keay L; Potter J; Lindley RI
    BMC Fam Pract; 2016 Nov; 17(1):152. PubMed ID: 27814691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and sustainability of deprescribing for hospitalized older patients near end of life: a systematic review.
    Cardona M; Stehlik P; Fawzy P; Byambasuren O; Anderson J; Clark J; Sun S; Scott I
    Expert Opin Drug Saf; 2021 Jan; 20(1):81-91. PubMed ID: 33213216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.